An updated review on transdermal drug delivery systems

Audumbar Digambar Mali, Ritesh Bathe, Manojkumar Patil

Abstract


Transdermal drug delivery systems (TDDS), also known as “patches,” are dosage forms designed to deliver a therapeutically effective amount of drug across a patient’s skin. In order to deliver therapeutic agents through the human skin for systemic effects, the comprehensive morphological, biophysical and physicochemical properties of the skin are to be considered. Transdermal delivery provides a leading edge over injectables and oral routes by increasing patient compliance and avoiding first pass metabolism respectively. Transdermal delivery not only provides controlled, constant administration of the drug, but also allows continuous input of drugs with short biological half-lives and eliminates pulsed entry into systemic circulation, which often causes undesirable side effects. The TDDS review articles provide valuable information regarding the transdermal drug delivery systems and its evaluation process details as a ready reference for the research scientist who is involved in TDDS. With the advancement in technology Pharma industries have trendified all its resources. Earlier we use convectional dosage form but now we use novel drug delivery system. One of greatest innovation of novel drug delivery is transdermal patch. The advantage of transdermal drug delivery system is that it is painless technique of administration of drugs. 


Keywords


Transdermal drug delivery systems (TDDS), Diffusion, First-generation TDS, Second-generation TDS, Polymer Matrix, Permeation enhancers, Iontophoresis, Microneedles

Full Text:

PDF

References


Shaila L, Pandey S and Udupa N. Design and Evaluation of Matrix Type Membrane Controlled Transdermal Drug Delivery System of Nicotin Suitable for Use in Smoking Cessation. Indian Journ. Pharm. Sci. 2006;68: 179-184

Aarti N, Louk A.R.M.P, Russsel.O.P and Richard H.G. Mechanism of Oleic Acid Induced Skin Permeation Enhancement in Vivo in Humans. Jour. Control. Release. 1995; 37: 299-306.

Brown M.B and Jones S.A. Hyaluronic Acid: A Unique Topical Vehicle for Localized Drug Delivery of Drugs to the Skin. Jedv 2000; 19: 308-318.

Tsai J.C, Guy R.H, Thornfeldt C.R, Gaow.N, Feingold K.R and Elias P.M. Metabolic Approaches to Enchance Transdermal Drug Delivery. Jour. Pharm. Sci. 1998; 85:643-648.

Berner B and John V.A. Pharmacokinetic Characterization of Transdermal Delivery Systems. Jour. Clinical Pharmacokinetics. 1994; 26 (2): 121-34.

Baker W and Heller J. Material Selection for Transdermal Delivery Systems. In Transdermal Drug Delivery: Developmental Issues and Research Initiatives, J.Hadgraft and R.H.Guys, Eds. Marcel Dekker, Inc.,New York. 1989 Pp. 293-311.

Wiechers J. Use of Chemical Penetration Enhancers in Transdermal Drug Delivery-Possibilities and Difficulties. Acta Pharm. 1992: 4: 123.

Yamamoto T, Katakabe K, Akiyoshi K, Kan K and Asano T. Topical Application of Glibenclamide Lowers Blood Glucose Levels in Rats. Diabetes Res. Clin. Pract. 1990; 8: 19-22.

Rhaghuram Rk, Muttalik S, Reddy S. Once – Daily Sustained- Release Matrix Tablets of Nicorandil: Formulation and Invitro Evaluation. Aaps Pharm.Scitech. 2003; 4(4):480–488.

Shaila L, Pandey S, Udupa N. Design and Evaluation of Matrix Type Membrane Controlled Transdermal Drug Delivery System of Nicotin Suitable for Use in Smoking Cessation. Indian Journal of Pharmaceutical Sciences. 2006; 68:179-184.

Aarti N, Louk Armp, Russsel Op. Richard Hg. Mechanism of Oleic Acid Induced Skin Permeation Enhancement in Vivo in Humans. Jour. Control. Release. 1995; 37:299-306.

Baichwal Mr. Polymer Films as Drug Delivery Systems Advances in Drug Delivery Systems. Bombay, Msr Foundation; 1985; 136-147.

Vyas Sp, Khar Rk. Targetted and Controlled Drug Delivery Novel Carrier System. 1st Ed. Cbs Publishers and Distributors New Delhi. 2002; 411- 447.

Singh J, Tripathi Kt, Sakia Tr. Effect of Penetration Enhancers on The in vitro Transport of Ephedrine Through Rate Skin and Human Epidermis From Matrix Based Transdermal Formulations. Drug Dev Ind Pharm. 1993; 19:1623-1628.

Ghosh B, Preethi Gb, Mishra R, Parcha V. Transdermal Delivery of Ibuprofen ond Its Prodrugs by Passive Diffusion and Iontophoresis. Int J Pharm Pharm Sci. 2010; 2(1):79-85.

Rajesh N, Siddaramaiah, Gowda Dv, Somashekar Cn. Formulation and Evaluation of Biopolymer Based Transdermal Drug Delivery. Int J Pharm Pharm Sci. 2010; 2(2):142-147.

Hanumanaik M, Patil U, Kumar G, Patel S K, Singh I, Jadatkar K,. Design, Evaluation and Recent Trends in Transdermal Drug Delivery System: A Review. IJPSR. 2012; 3(8): 2393-2406.

Chandrashekhar N S, Shobha Rani R H. Physicochemical and Pharmacokinetic Parameters in Drug Selection and Loading of Transdermal Drug Delivery. Indian Journal of Pharmaceutical Sciences. 2008; 70(1): 94‐96.

Scheindlin S. Transdermal Drug Delivery: Past, Present, Future. Molecular Interventions. 2004; 4(6): 308‐312.

Aungst Bj Structure/Effect Studies of Fatty Acid Isomers as Skin Penetration Enhancers and Skin Irritants. Pharm Res. 1989; 6: 244–7.

Ongpipattanakul B, Burnette Rr, Potts Ro, Francoeur Ml Evidence That Oleic Acid Exists in A Separate Phase Within Stratum Corneum Lipids. Pharm Res. 1991; 8: 350–4.

Sinha Vr, Kaur Pm Permeation Enhancers for Transdermal Drug Delivery. Drug Dev Ind Pharm. 2000; 26: 1131–40.

Barry Bw, Williams Ac Terpenes As Skin Penetration Enhancers. Marcel Dekker. 1993; 9: 95–111.

Williams Ac, Barry Bw, Terpenes and the Lipid–Protein-Partitioning Theory of Skin Penetration Enhancement. Pharm Res. 1991; 8: 17–24.

Vaddi Hk, Ho Pc, Chan Sy, Terpenes in Propylene Glycol as Skin-Penetration Enhancers: Permeation and Partition of Haloperidol, Fourier Transform Infrared Spectroscopy and Differential Scanning Calorimetry. J Pharm Sci. 2002; 91: 1639–51.

Asbill Cs, El-Kattan Af, Michniak B, Enhancement of Transdermal Drug Delivery: Chemical And Physical Approaches. Crit Rev Ther Drug Carrier Syst. 2000; 17: 621–58.

Krishnaiah Ys, Satyanarayana V, Bhaskar P, Influence of Menthol and Pressure-Sensitive Adhesives on the in vivo Performance of Membrane-Moderated Transdermal Therapeutic System of Nicardipine Hydrochloride in Human Volunteers. Eur J Pharm Biopharm.2002; 55: 329–37.

Okabe H, Obata Y, Takayama K, Nagai T., Percutaneous Absorption Enhancing Effect and Skin Irritation of Monocyclic Monoterpenes. Drug Des Deliv.1990; 6: 229–38.

Barry Bw., The Lpp Theory of Skin Penetration Enhancement. Maturitas. 1998; 29: 165–85.

Ghafourian T, Zandasrar P, Hamishekar H, Nokhodchi A, the Effect of Penetration Enhancers on Drug Delivery Through Skin: A Qsar Study. J Control Release.2004; 99: 113–25.

Montia D, Saettone Mf, Giannaccini B, Angeli Dg, Enhancement of Transdermal Penetration of Dapiprazole Through Hairless Mouse Skin. J Control Release.1995; 33: 71–7.

Bharadwaj S, Gupta Gd, Sharma Vk. Topical Gel: A Novel Approach for Drug Delivery. J Chem. Bio. Phy. Sci. 2012; 2(2): 856-867.

Sharma N, Parashar B, Sharma S, Mahajan U. Blooming Pharma Industry With Transdermal Drug Delivery System. Indo Global J Pharm. Sci. 2012; 2(3): 262-278.

Darwhekar G, Jain Dk, Paditar Vk. Formulation and Evaluation of Transdermal Drug Delivery System of Clopidogrel Bisulfate. Asi. J. Pharmacy Life Sci. 2011; 1(3): 269-278.

Berner B, John Va. Pharmacokinetic Characterization of Transdermal Delivery System. J. Clin. Pharmaco. 1994; 26(2): 121-134.

Arunachalam A, Karthikeyan M, Kumar Vd, Prathap M, Sethuraman S, Ashutoshkumar S, Manidipa S. Transdermal Drug Delivery System: A Review. Current Pharma Res. 2010; 1(1):70-81.

Kumar Sr, Jain A, Nayak S. Development and Evaluation of Transdermal Patches of Colchicine. Der Pharmacia Lettre. 2012; 4(1): 330-343.

Patel, D., Sunita, A., Parmar B., Bhura N., Transdermal Drug Delivery System: A Review. The Pharma Innovation. 2012; 1(4): 66-75.

Sharma N., Agarwal G., Rana A.C., Ali Bha Tz.,Kumar D. A Review: Transdermal Drug Delivery System: A Tool for Novel Drug Delivery System. International Journal of Drug Development & Research. 2011; 3(3): 70-84.

Das, U. S., Pande K.H., an Overview of Diabetes Mellitus, World Journal of Pharmacy and Pharmaceutical Sciences. 2013; 2(1): 161-178.

Rangari N.T., Kalyankar T.M., Puranik P.K., Chaudhar S.R. Permeation Studies Of Pioglitazone Hcl From Ficuscarica Fruit Mucilage Matrix Transdermal Patches,International Journal of Pharmaceutical Sciences and Research. 2012; 3(10): 3927-3931.

Kim Mk, Zhao H, Lee Ch, Kim D.D. Formulation Of A Reservoir-Type Testosterone Transdermal Delivery System .Int J Pharm. 2011; 219(1-2): 51-9.

M. Aqil and Asgarali, Monolithic Matrix Type Transdermal Drug Delivery Systems of Pinacidil Monohydrate: In Vitro Characterisation. European Journal of Pharmaceutics and Biopharmaceutics. 2001: 54: 161–164.

Raghuraman,S.,Velrajan, Ravi,R., Jeybalan,B., Johnson,D.B., Andsankar,V.,.Design And Evaluation of Propranolol Hydrochloride Buccal Films. Indian Journal of Pharmaceutical Sciences. 2001; 61(1): 32-36.

Sharma N, Agarwal G, Rana Ac, Bhat Za, Kumar D. A Review: Transdermal Drug Delivery System: A Tool For Novel Drug Delivery System. Int. J. Drug Dev. Res. 2011; 3(3):70-84.

Shingade Gm, Quazi A, Sabale Pm, Grampurohit Nd, Gadhave Mv, Jadhav Sl, Gaikwad Dd. Review On: Recent Trend On Transdermal Drug Delivery System. J. Drug Deliv. Ther. 2012; 2(1): 66-75.

Shivaraj A, Selvam Rp, Mani Tt, Sivakumar T. Design and Evaluation of Transdermal Drug Delivery of Ketotifen Fumarate. Int. J. Pharm. Biomed. Res. 2010; 1(2):42-7.

Talegaonkar S, Tariq M, Alabood Rm. Design and Development of O/W Nanoemulsion for the Transdermal Delivery of Ondansetron. Bull. Pharm. Res. 2011; 1(3):18-30.

Tortara Gj, Grabowski Sr. Principles of Anatomy and Physiology. John Wiley & Sons. 1999.

Vishvakarama P, Agarwal S, Sharma R, Sharma S. Transdermal Drug Delivery System: Review. Int. J. Res.Pharm. 2012; 3(5):50-3.

Gaur Pk, Mishra S, Purohit S and Dave K. Transdermal Drug Delivery System: A Review. Asian Journal of Pharmaceutical and Clinical Research. 2009; 2(1): 14-20.

Singh M.C., Naik A.S and Sawant S.D., Transdermal Drug Delivery Systems with Major Emphasis on Transdermal Patches: A Review. Journal of Pharmacy Research. 2010; 3(10): 2537-2543.

Sakalle P, Dwivedi S and Dwivedi A. Design, Evaluation, Parameters and Marketed Products of Transdermal Patches: A Review. Journal of Pharmacy Research. 2010; 3(2): 235-240.

Wiechers J. Use of Chemical Penetration Enhancers in Transdermal Drug Delivery-Possibilities and Difficulties. Acta Pharm. 1992: 4: 123.

Yamamoto T, Katakabe K, Akiyoshi K, Kan K and Asano T. Topical Application of Glibenclamide Lowers Blood Glucose Levels in Rats. Diabetes Res. Clin. Pract. 1990; 8: 19-22.

Al- Khamis K, Davis S.S and Hadgraft J. Microviscosity and Drug Release From Topical Gel Formulations. Pharm. Res. 1986; 3: 214-217.

Anon. Transdermal Delivery Systems-General Drug Release Standards. Pharmacopeial Forum. 1980; 14: 3860-3865.

Ryan D. Gordon, and Tim A. Peterson, Transdermal Drug Delivery, Drug Delivery Technology. www.Drugdeliverytechnology.Com.




DOI: http://dx.doi.org/10.7439/ijasr.v1i6.2243

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Refbacks

  • There are currently no refbacks.


Copyright (c) 2015 International Journal of Advances in Scientific Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.